Ten-Year Plateau Phase in HumanImmunodeficiency Virus Induced MotorNeuron Disease upon AntiretroviralTherapy: A First Case from Eastern Africa

Citation: 
Marjolein E. de Bruin, MD1,2, Emmanuel V. Assey, MD1, Asha Osman, MD1, Kajiru Kilonzo, MD1, William P. Howlett, MD1, and Marieke C.J. Dekker, MD1
Publication year: 
2020

We report an individual with rapidly progressive motor neuron disease (MND), phenotypically compatible with amyotrophic lateral sclerosis (ALS). The patient described in this case report proved positive for human immunodefi-ciency virus (HIV) and was initiated on antiretroviral ther-apy (ART). Following ART he clinically stabilised over 10 years and deteriorated again due to noncompliance or ART resistance. HIV infection can give rise to an MND mimic, HIV-ALS. The improvement in response to ART supports the notion that HIV-ALS is a treatable entity also in Africa. This is the first case report of a patient with HIV-ALS and long term follow up in Sub-Saharan Africa. The report rais-es the suggestion that an additional (retro)virus can play a role in the aetiology of ALS